Otsuka America Pharmaceutical, Inc. (OAPI) and Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) will restructure in an effort to grow the pharmaceutical business worldwide. As part of this initiative, Mark Altmeyer was appointed president and chief executive officer, OAPI, and Dean R. Haubrich, Ph.D., has been appointed chairman, OAPI board. The restructuring includes establishing a Pharmaceutical Governance Committee and a Medical Device Governance Committee, responsibl...